Valence Labs
@valenceai.bsky.social
Industrializing scientific discovery to radically improve lives.
Powered by @recursionpharma.bsky.social
Powered by @recursionpharma.bsky.social
1/ Valence Labs is bringing together next generation of Montréal researchers and innovators in Bio-AI.
We are hosting a Bio-AI Show & Tell — a quick and fun showcase of ideas, demos and projects in ML.
RSVP here: luma.com/n47bshdx
We are hosting a Bio-AI Show & Tell — a quick and fun showcase of ideas, demos and projects in ML.
RSVP here: luma.com/n47bshdx
October 29, 2025 at 1:40 PM
1/ Valence Labs is bringing together next generation of Montréal researchers and innovators in Bio-AI.
We are hosting a Bio-AI Show & Tell — a quick and fun showcase of ideas, demos and projects in ML.
RSVP here: luma.com/n47bshdx
We are hosting a Bio-AI Show & Tell — a quick and fun showcase of ideas, demos and projects in ML.
RSVP here: luma.com/n47bshdx
1/ Valence Labs, @recursionpharma.bsky.social's AI research engine, is at ICML this week!
Two of our scientists, @jhartford.bsky.social and Ihab Bendidi are presenting posters on work featured in their papers 👇🧵
Two of our scientists, @jhartford.bsky.social and Ihab Bendidi are presenting posters on work featured in their papers 👇🧵
July 18, 2025 at 1:51 PM
1/ Valence Labs, @recursionpharma.bsky.social's AI research engine, is at ICML this week!
Two of our scientists, @jhartford.bsky.social and Ihab Bendidi are presenting posters on work featured in their papers 👇🧵
Two of our scientists, @jhartford.bsky.social and Ihab Bendidi are presenting posters on work featured in their papers 👇🧵
1/ We are excited to open-source the SynFlowNet-Boltz-2 trainer today! 🧵
🚀 Accelerating Boltz-2 for more efficient structure-based hit discovery. Today, Recursion is open-sourcing its SynFlowNet-Boltz trainer to enable more efficient design of high-affinity binders needed for successful early-stage drug discovery. Learn more: www.recursion.com/news/beyond-... #TechBio 🧪
Beyond Boltz-2: Toward More Powerful Drug Discovery Tools
www.recursion.com
June 27, 2025 at 5:51 PM
1/ We are excited to open-source the SynFlowNet-Boltz-2 trainer today! 🧵
Pleased to have hosted the 2025 Molecular Machine Learning Conference last week at @mila-quebec.bsky.social
Thank you to everyone who joined us and shared their valuable insights!
We hope to see you all again soon.
Thank you to everyone who joined us and shared their valuable insights!
We hope to see you all again soon.
We had a great turnout for #MoML 2025.
Sponsored by Recursion & @valenceai.bsky.social, MoML convenes researchers from academia & industry to discuss how ML can address key scientific goals related to molecular modeling, molecular interactions & therapeutic design.
👉https://portal.ml4dd.com/ 🧪
Sponsored by Recursion & @valenceai.bsky.social, MoML convenes researchers from academia & industry to discuss how ML can address key scientific goals related to molecular modeling, molecular interactions & therapeutic design.
👉https://portal.ml4dd.com/ 🧪
June 25, 2025 at 8:09 PM
Pleased to have hosted the 2025 Molecular Machine Learning Conference last week at @mila-quebec.bsky.social
Thank you to everyone who joined us and shared their valuable insights!
We hope to see you all again soon.
Thank you to everyone who joined us and shared their valuable insights!
We hope to see you all again soon.
Looking forward to seeing everyone at MoML this Wednesday, June 18th, at @mila-quebec.bsky.social in Montréal.
We anticipate a day of engaging discussions, talks and poster presentations, exploring research at the intersection of machine learning and drug discovery.
Agenda Here: portal.ml4dd.com
We anticipate a day of engaging discussions, talks and poster presentations, exploring research at the intersection of machine learning and drug discovery.
Agenda Here: portal.ml4dd.com
June 17, 2025 at 1:03 PM
Looking forward to seeing everyone at MoML this Wednesday, June 18th, at @mila-quebec.bsky.social in Montréal.
We anticipate a day of engaging discussions, talks and poster presentations, exploring research at the intersection of machine learning and drug discovery.
Agenda Here: portal.ml4dd.com
We anticipate a day of engaging discussions, talks and poster presentations, exploring research at the intersection of machine learning and drug discovery.
Agenda Here: portal.ml4dd.com
Proud to share @recursionpharma.bsky.social's exciting announcement on Boltz-2! Valence Labs, Recursion’s AI research engine, contributed to the foundational research supporting the @mit.edu team led by Regina Barzilay.
Learn more about Boltz-2 here: www.rxrx.ai/boltz-2
Learn more about Boltz-2 here: www.rxrx.ai/boltz-2
More on Boltz-2, the new open source AI model from MIT & Recursion capable of predicting protein binding affinity w/ unprecedented speed, scale & accuracy -- the 1st model to combine structure & binding affinity prediction, approaching FEP accuracy w/ 1000X the speed. www.youtube.com/watch?v=gRtr...
New Open Source Model from MIT & Recursion Solves Major Hurdle in AI Drug Discovery
YouTube video by Recursion
www.youtube.com
June 6, 2025 at 7:13 PM
Proud to share @recursionpharma.bsky.social's exciting announcement on Boltz-2! Valence Labs, Recursion’s AI research engine, contributed to the foundational research supporting the @mit.edu team led by Regina Barzilay.
Learn more about Boltz-2 here: www.rxrx.ai/boltz-2
Learn more about Boltz-2 here: www.rxrx.ai/boltz-2
1/ We're excited to announce our speaker lineup for MoML 2025!
Join us on June 18th, 2025, at Mila in Montreal for a day focused on the intersection of machine learning and drug discovery. 🧵
Join us on June 18th, 2025, at Mila in Montreal for a day focused on the intersection of machine learning and drug discovery. 🧵
June 3, 2025 at 1:44 PM
1/ We're excited to announce our speaker lineup for MoML 2025!
Join us on June 18th, 2025, at Mila in Montreal for a day focused on the intersection of machine learning and drug discovery. 🧵
Join us on June 18th, 2025, at Mila in Montreal for a day focused on the intersection of machine learning and drug discovery. 🧵
Reposted by Valence Labs
A new perspective paper from Recursion and our AI research engine @valenceai.bsky.social lays out our vision for a virtual cell as a system that can reliably drive the discovery of new drugs via an iterative loop of: predict, explain, discover. arxiv.org/abs/2505.14613 #TechBio 🧪
May 22, 2025 at 3:13 PM
A new perspective paper from Recursion and our AI research engine @valenceai.bsky.social lays out our vision for a virtual cell as a system that can reliably drive the discovery of new drugs via an iterative loop of: predict, explain, discover. arxiv.org/abs/2505.14613 #TechBio 🧪
1/ Introducing TxPert: a new model that predicts transcriptional responses across diverse biological contexts
It’s designed to generalize across unseen single-gene perturbations, novel combinations of gene perturbations, and even new cell types 🧵
www.valencelabs.com/txpert-predi...
It’s designed to generalize across unseen single-gene perturbations, novel combinations of gene perturbations, and even new cell types 🧵
www.valencelabs.com/txpert-predi...
TxPert: Predicting Cellular Responses to Unseen Genetic Perturbations - Valence Labs
We introduce TxPert: a state-of-the-art model that leverages multiple biological knowledge networks to accurately predict transcriptional responses under OOD scenarios.
www.valencelabs.com
May 22, 2025 at 1:52 PM
1/ Introducing TxPert: a new model that predicts transcriptional responses across diverse biological contexts
It’s designed to generalize across unseen single-gene perturbations, novel combinations of gene perturbations, and even new cell types 🧵
www.valencelabs.com/txpert-predi...
It’s designed to generalize across unseen single-gene perturbations, novel combinations of gene perturbations, and even new cell types 🧵
www.valencelabs.com/txpert-predi...
1/ At Valence Labs, @recursionpharma.bsky.social's AI research engine, we’re focused on advancing drug discovery outcomes through cutting-edge computational methods
Today, we're excited to share our vision for building virtual cells, guided by the predict-explain-discover framework 🧵
Today, we're excited to share our vision for building virtual cells, guided by the predict-explain-discover framework 🧵
May 20, 2025 at 3:55 PM
1/ At Valence Labs, @recursionpharma.bsky.social's AI research engine, we’re focused on advancing drug discovery outcomes through cutting-edge computational methods
Today, we're excited to share our vision for building virtual cells, guided by the predict-explain-discover framework 🧵
Today, we're excited to share our vision for building virtual cells, guided by the predict-explain-discover framework 🧵
(1/3)The poster submission deadline for MoML 2025 has been extended to May 20th, 2025.
Don’t miss an opportunity to share your work at this years conference.
Submit here: portal.ml4dd.com/moml-2025-po...
Don’t miss an opportunity to share your work at this years conference.
Submit here: portal.ml4dd.com/moml-2025-po...
May 13, 2025 at 1:19 PM
(1/3)The poster submission deadline for MoML 2025 has been extended to May 20th, 2025.
Don’t miss an opportunity to share your work at this years conference.
Submit here: portal.ml4dd.com/moml-2025-po...
Don’t miss an opportunity to share your work at this years conference.
Submit here: portal.ml4dd.com/moml-2025-po...
(1/3) Speaker Spotlight: Gabriele Corso
We’re excited to welcome @gcorso.bsky.social to MoML 2025 on June 18th — hosted @mila-quebec.bsky.social.
Gabriele is a PhD student at @mit.edu @csail.mit.edu developing ML methods for structural biology and drug discovery.
We’re excited to welcome @gcorso.bsky.social to MoML 2025 on June 18th — hosted @mila-quebec.bsky.social.
Gabriele is a PhD student at @mit.edu @csail.mit.edu developing ML methods for structural biology and drug discovery.
April 29, 2025 at 6:00 PM
(1/3) Speaker Spotlight: Gabriele Corso
We’re excited to welcome @gcorso.bsky.social to MoML 2025 on June 18th — hosted @mila-quebec.bsky.social.
Gabriele is a PhD student at @mit.edu @csail.mit.edu developing ML methods for structural biology and drug discovery.
We’re excited to welcome @gcorso.bsky.social to MoML 2025 on June 18th — hosted @mila-quebec.bsky.social.
Gabriele is a PhD student at @mit.edu @csail.mit.edu developing ML methods for structural biology and drug discovery.
(1/3) Speaker Spotlight: Dr. Smita Krishnaswamy
We’re thrilled to welcome Dr. Smita Krishnaswamy to MoML 2025 on June 18th - hosted @mila-quebec.bsky.social
Dr. Krishnaswamy is an Associate Professor of Genetics & Computer Science at @yaleschoolofmed.bsky.social
We’re thrilled to welcome Dr. Smita Krishnaswamy to MoML 2025 on June 18th - hosted @mila-quebec.bsky.social
Dr. Krishnaswamy is an Associate Professor of Genetics & Computer Science at @yaleschoolofmed.bsky.social
April 25, 2025 at 1:18 PM
(1/3) Speaker Spotlight: Dr. Smita Krishnaswamy
We’re thrilled to welcome Dr. Smita Krishnaswamy to MoML 2025 on June 18th - hosted @mila-quebec.bsky.social
Dr. Krishnaswamy is an Associate Professor of Genetics & Computer Science at @yaleschoolofmed.bsky.social
We’re thrilled to welcome Dr. Smita Krishnaswamy to MoML 2025 on June 18th - hosted @mila-quebec.bsky.social
Dr. Krishnaswamy is an Associate Professor of Genetics & Computer Science at @yaleschoolofmed.bsky.social
(1/7) The team at Valence Labs—powered by @recursionpharma.bsky.social will be at @iclr-conf.bsky.social in Singapore this week, where we’ll be co-hosting a TechBio social on Friday, April 25th.
Join us at the top of the Marina Bay Sands. RSVP: lu.ma/nts2d8uj
See below for a summary of our papers👇
Join us at the top of the Marina Bay Sands. RSVP: lu.ma/nts2d8uj
See below for a summary of our papers👇
April 21, 2025 at 5:51 PM
(1/7) The team at Valence Labs—powered by @recursionpharma.bsky.social will be at @iclr-conf.bsky.social in Singapore this week, where we’ll be co-hosting a TechBio social on Friday, April 25th.
Join us at the top of the Marina Bay Sands. RSVP: lu.ma/nts2d8uj
See below for a summary of our papers👇
Join us at the top of the Marina Bay Sands. RSVP: lu.ma/nts2d8uj
See below for a summary of our papers👇
(1/5) The Molecular Machine Learning Conference (MoML) is back @mila-quebec.bsky.social this June 18th.
Join researchers advancing machine learning, molecular modeling, and therapeutic design.
Tickets are free for students.
Register Today: portal.ml4dd.com/events/molec...
Join researchers advancing machine learning, molecular modeling, and therapeutic design.
Tickets are free for students.
Register Today: portal.ml4dd.com/events/molec...
April 17, 2025 at 1:20 PM
(1/5) The Molecular Machine Learning Conference (MoML) is back @mila-quebec.bsky.social this June 18th.
Join researchers advancing machine learning, molecular modeling, and therapeutic design.
Tickets are free for students.
Register Today: portal.ml4dd.com/events/molec...
Join researchers advancing machine learning, molecular modeling, and therapeutic design.
Tickets are free for students.
Register Today: portal.ml4dd.com/events/molec...
Reposted by Valence Labs
Advancing our vision for a virtual cell: In a presentation at #JPM2025, CEO Chris Gibson shared his vision for #TechBio, in which biol & chem datasets & highly predictive ML models, including advanced protein folding, will allow us to build a true virtual cell. ir.recursion.com/static-files...
January 13, 2025 at 6:42 PM
Advancing our vision for a virtual cell: In a presentation at #JPM2025, CEO Chris Gibson shared his vision for #TechBio, in which biol & chem datasets & highly predictive ML models, including advanced protein folding, will allow us to build a true virtual cell. ir.recursion.com/static-files...
The Valence team was proud to share our research at NeurIPS last week. We had 14 papers across the main conference and workshops.
At the Foundation Models for Science workshop, Valence and @recursionpharma.bsky.social researchers won first, second, and third place 🧵
At the Foundation Models for Science workshop, Valence and @recursionpharma.bsky.social researchers won first, second, and third place 🧵
December 20, 2024 at 6:25 PM
The Valence team was proud to share our research at NeurIPS last week. We had 14 papers across the main conference and workshops.
At the Foundation Models for Science workshop, Valence and @recursionpharma.bsky.social researchers won first, second, and third place 🧵
At the Foundation Models for Science workshop, Valence and @recursionpharma.bsky.social researchers won first, second, and third place 🧵
Valence scientist Michael Craig will serve as the Senior Chair for the Drug Discovery and Development roundtable at the ML4H conference today.
This session will focus on the role of LLMs and foundation models in accelerating drug discovery.
Learn more: ahli.cc/ml4h/researc...
This session will focus on the role of LLMs and foundation models in accelerating drug discovery.
Learn more: ahli.cc/ml4h/researc...
December 16, 2024 at 8:33 PM
Valence scientist Michael Craig will serve as the Senior Chair for the Drug Discovery and Development roundtable at the ML4H conference today.
This session will focus on the role of LLMs and foundation models in accelerating drug discovery.
Learn more: ahli.cc/ml4h/researc...
This session will focus on the role of LLMs and foundation models in accelerating drug discovery.
Learn more: ahli.cc/ml4h/researc...
Thank you to everyone who attended our event at #NeurIPS2024 with @RecursionPharma and @nvidia earlier this week.
We're presenting multiple posters at the workshops today. Talk to us and learn more about our open roles. We're hiring: www.valencelabs.com/careers
Workshop schedule👇
We're presenting multiple posters at the workshops today. Talk to us and learn more about our open roles. We're hiring: www.valencelabs.com/careers
Workshop schedule👇
December 15, 2024 at 5:22 PM
Thank you to everyone who attended our event at #NeurIPS2024 with @RecursionPharma and @nvidia earlier this week.
We're presenting multiple posters at the workshops today. Talk to us and learn more about our open roles. We're hiring: www.valencelabs.com/careers
Workshop schedule👇
We're presenting multiple posters at the workshops today. Talk to us and learn more about our open roles. We're hiring: www.valencelabs.com/careers
Workshop schedule👇
Generative models often create molecules that are hard to synthesize.
Tomorrow, we present SynFlowNet, a GFlowNet designed to generate synthesizable molecules using documented reactions and purchasable materials.
Learn more at the MLSB workshop: arxiv.org/abs/2405.01155
Tomorrow, we present SynFlowNet, a GFlowNet designed to generate synthesizable molecules using documented reactions and purchasable materials.
Learn more at the MLSB workshop: arxiv.org/abs/2405.01155
December 14, 2024 at 10:53 PM
Generative models often create molecules that are hard to synthesize.
Tomorrow, we present SynFlowNet, a GFlowNet designed to generate synthesizable molecules using documented reactions and purchasable materials.
Learn more at the MLSB workshop: arxiv.org/abs/2405.01155
Tomorrow, we present SynFlowNet, a GFlowNet designed to generate synthesizable molecules using documented reactions and purchasable materials.
Learn more at the MLSB workshop: arxiv.org/abs/2405.01155
🧵 At NeurIPS last year, we introduced Sequential Attachment-based Fragment Embeddings (SAFE), a novel line notation for chemical structures that reimagines SMILES strings as an unordered sequence of interconnected fragment blocks.
youtu.be/oJsj5vWmD3c
youtu.be/oJsj5vWmD3c
December 13, 2024 at 11:12 PM
🧵 At NeurIPS last year, we introduced Sequential Attachment-based Fragment Embeddings (SAFE), a novel line notation for chemical structures that reimagines SMILES strings as an unordered sequence of interconnected fragment blocks.
youtu.be/oJsj5vWmD3c
youtu.be/oJsj5vWmD3c
Missed the event yesterday? Our team is still at NeurIPS today and throughout the workshops.
Come talk to us and learn more about open roles. We’re hiring for both full-time and internship positions: www.valencelabs.com/careers
Come talk to us and learn more about open roles. We’re hiring for both full-time and internship positions: www.valencelabs.com/careers
December 13, 2024 at 5:40 PM
Missed the event yesterday? Our team is still at NeurIPS today and throughout the workshops.
Come talk to us and learn more about open roles. We’re hiring for both full-time and internship positions: www.valencelabs.com/careers
Come talk to us and learn more about open roles. We’re hiring for both full-time and internship positions: www.valencelabs.com/careers
Tonight is our TechBio social with @recursionpharma.bsky.social and NVIDIA.
Meet fellow scientists, engineers, and founders working at the intersection of ML and drug discovery at Science World.
Space is limited. Join the waitlist: lu.ma/biikt7ox
Meet fellow scientists, engineers, and founders working at the intersection of ML and drug discovery at Science World.
Space is limited. Join the waitlist: lu.ma/biikt7ox
December 13, 2024 at 12:24 AM
Tonight is our TechBio social with @recursionpharma.bsky.social and NVIDIA.
Meet fellow scientists, engineers, and founders working at the intersection of ML and drug discovery at Science World.
Space is limited. Join the waitlist: lu.ma/biikt7ox
Meet fellow scientists, engineers, and founders working at the intersection of ML and drug discovery at Science World.
Space is limited. Join the waitlist: lu.ma/biikt7ox
Multimodal techniques rely on paired samples to learn common representations, but these samples are hard to collect in biology where measurement devices often destroy samples.
How do we enable a multimodal future in TechBio? Learn more today at NeurIPS.
youtu.be/7a29mGz9LXI
How do we enable a multimodal future in TechBio? Learn more today at NeurIPS.
youtu.be/7a29mGz9LXI
December 12, 2024 at 4:40 PM
Multimodal techniques rely on paired samples to learn common representations, but these samples are hard to collect in biology where measurement devices often destroy samples.
How do we enable a multimodal future in TechBio? Learn more today at NeurIPS.
youtu.be/7a29mGz9LXI
How do we enable a multimodal future in TechBio? Learn more today at NeurIPS.
youtu.be/7a29mGz9LXI
MolPhenix is a foundation model that can predict the effect of any given molecule and concentration pair on phenotypic cell assays and cell morphology.
We'll be presenting this work at NeurIPS next week. Come chat with us!
Paper: arxiv.org/pdf/2409.08302
We'll be presenting this work at NeurIPS next week. Come chat with us!
Paper: arxiv.org/pdf/2409.08302
December 4, 2024 at 2:17 PM
MolPhenix is a foundation model that can predict the effect of any given molecule and concentration pair on phenotypic cell assays and cell morphology.
We'll be presenting this work at NeurIPS next week. Come chat with us!
Paper: arxiv.org/pdf/2409.08302
We'll be presenting this work at NeurIPS next week. Come chat with us!
Paper: arxiv.org/pdf/2409.08302